W Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
W Advisors's PFE Position: Q3 2026 in Review
W Advisors increased its Pfizer (PFE) stake by 4.2% in Q3 2026, buying an estimated $11K and bringing the position to 10,253 shares worth $292K. The position accounts for 0.13% of the portfolio, ranked #123.
W Advisors first reported a position in PFE in Q4 2021 and has held it in 17 quarters since. The position peaked at $638K in Q4 2021. 2,593 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- W Advisors held 10,253 shares of Pfizer worth $292K as of Q3 2026.
- W Advisors bought 412 Pfizer shares in Q3 2026, an estimated $11K.
- Pfizer made up 0.13% of W Advisors's portfolio in Q3 2026, its #123 holding.
- W Advisors first reported a position in Pfizer in Q4 2021 and has held it in 17 quarters since.
- W Advisors's Pfizer position peaked at $638K in Q4 2021.
- 2,593 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on W Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.